Some of Thursday's midday movers:» Read More
Yesterday and today thousands of kids and healthcare workers around the country started getting AstraZeneca's H1N1 FluMist, the vaccine that's sprayed into the nose. The first shots from Novartis and Sanofi-Aventis may be available later this week. GlaxoSmithKline and Baxter are still waiting for the FDA to approve their vaccines.
The CDC announced today that healthcare workers in Tennessee and Indiana would be amongst the first to get swine flu vaccinations. The outbreak of the H1N1 swine flu virus has sadly killed over 3,900 peope per a report by the World Health Organization (WHO) on September 25th. At the same time the race to battle the pandemic has propped up the shares of biotech companies that promise solutions.
Charles Bobrinskoy, vice chairman and director of research at Ariel Investments and Marc Harris, co-head of Global Research at RBC Capital Markets shared their insights on where to invest in a low volume environment and what investors should be watching for next week.
Stock markets are up 50 percent from the March lows and you need to prepare for a correction. Whether you believe that a 10 percent pullback is reasonable or that something greater is coming, it makes sense to invest with the perspective that a retracement is coming and still be positioned for more market movement forward.
Cramer makes the call on viewers' favorite stocks.
Earnings season should provide a fresh view of the U.S. economy and may shake the stock market out of its summer doldrums.
As flu season goes into high gear in the southern hemisphere, the U.S. Dept. of Homeland Security is preparing for a potential flu outbreak in the United States, according to its top official.
The Mad Money explains Friday’s move and tells us what to expect for the coming week.
To almost no one's surprise, for the first time in 41 years, the World Health Organization has declared a full-blown swine flu pandemic. But the declaration is tied more to the geographic spread of the virus than it is to its virulence.
Yesterday's close marked the 3-month anniversary since the markets hit their closing lows on March 9. Here are the biggest gainers and losers on the S&P since then.
Following are the day’s biggest winners and losers. Find out why shares of Elan and Las Vegas Sands popped while KeyCorp and Baxter dropped.
The World Health Organisation warned on Friday against a false sense of security from waning and apparently mild outbreaks of H1N1 flu, saying the worst may not be over.
The futures are down again this morning with uncertainty of the impact that the swine flu will ultimately have. So far, nearly 150 people have died in Mexico from the disease as it continues to spread around the world. Here are some of the stocks that moved most as the story has developed.
Concerns that the recent outbreak of swine flu could reach pandemic proportions dragged down the Dow and S&P Monday with investors hammering airlines, hotels and more.
Concerns that the swine flu could reach pandemic proportions sent money moving. Who wins and who loses?
Investors with a short time horizon and low tolerance for risk may want to avoid the group, but the patient and the bold may well be rewarded over time.
After a five-week rally, stocks face one of their toughest challenges yet - a very nasty earnings season.
A number of takeover rumors have been making the rounds, an encouraging sign that capitalistic optimism is returning to the markets.
OptionMonster Jon Najarian reveals where he's spotted some unusually bullish action.
Both Pete and Jon Najarian are seeing some unusual options action. What do they make of it?